LIVE FROM THE DATABASETRANSACTIONS 723,642COMPANIES 6,572LATEST TRADE Oct 27UPDATED Oct 28, 06:15 AM
Reporting ownerCIK 0001672470

Hugh Rosen

11 transactions in one company, from April 30, 2025 to June 25, 2025.

Transactions
111 company
Bought · P
$0open market
Sold · S
$0open market
Net
+$0net buying

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Regulus Therapeutics Inc.RGLS11——

All transactions

11 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValueHeld after
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer60,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer30,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer15,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer30,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer9,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer4,000——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer2,325——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirDERIVJun 25DReturned to issuer4,650——0derivatives
Regulus Therapeutics Inc.RGLSHugh RosenDirJun 25DReturned to issuer57,292——0
Regulus Therapeutics Inc.RGLSHugh RosenDirJun 25UTender offer6,979——57,292
Regulus Therapeutics Inc.RGLSHugh RosenDirApr 30AAward62,500$0.00—64,271